The paper's citation list
No. | The paper's citation list |
|---|
1 | Engineered bacterial extracellular vesicles for central nervous system diseases. 2023;364:46 doi: 10.1016/j.jconrel.2023.10.027 |
2 | Intestinal organoids and organoids extracellular vesicles for inflammatory bowel disease treatment. 2023;465:142842 doi: 10.1016/j.cej.2023.142842 |
3 | Metabolomics analysis of extracellular vesicles derived from bovine colostrum and mature milk. 2024;2:9240078 doi: 10.26599/FSAP.2024.9240078 |
4 | Novel administration strategies for tissue-specific delivery of extracellular vesicles. 2024;4:100057 doi: 10.1016/j.vesic.2024.100057 |
5 | Utilization of Probiotic-Derived Extracellular Vesicles as
Postbiotics and Their Role in Mental Health Therapeutics. 2024;44:1252 doi: 10.5851/kosfa.2024.e92 |
6 | Garlic-derived nanoparticles inhibit tumor by activating tumor-infiltrating γδT cells. 2025;18:94907145 doi: 10.26599/NR.2025.94907145 |
7 | Mechanism of selenium-doped black phosphorus nanosheets wrapped with biomimetic tumor cell membrane for prostate cancer immunotherapy. 2025;176:214339 doi: 10.1016/j.bioadv.2025.214339 |
8 | Exosomes: from biology to immunotherapy in infectious diseases. 2023;55:79 doi: 10.1080/23744235.2022.2149852 |
9 | Bioengineered bacterial extracellular vesicles for targeted delivery of an osteoclastogenesis-inhibitory peptide to alleviate osteoporosis. 2025;382:113751 doi: 10.1016/j.jconrel.2025.113751 |
10 | Intra-articular nanodrug delivery strategies for treating osteoarthritis. 2023;28:103482 doi: 10.1016/j.drudis.2022.103482 |
11 | A simple polydopamine‐based platform for engineering extracellular vesicles with brain‐targeting peptide and imaging probes to improve stroke outcome. 2025;14: doi: 10.1002/jev2.70031 |
12 | Advancements in the application of ablative therapy and its combination with immunotherapy in anti-cancer therapy. 2025;1880:189285 doi: 10.1016/j.bbcan.2025.189285 |
13 | Tiny but mighty: Possible roles of bacterial extracellular vesicles in gut‐liver crosstalk for non‐alcoholic fatty liver disease. 2022;2: doi: 10.1002/ctd2.115 |
14 | Bone-targeted bioengineered bacterial extracellular vesicles delivering siRNA to ameliorate osteoporosis. 2023;255:110610 doi: 10.1016/j.compositesb.2023.110610 |
15 | Opportunities and challenges of bacterial extracellular vesicles in regenerative medicine. 2025;23: doi: 10.1186/s12951-024-02935-1 |
16 | An Injectable Hydrogel Bioimplant Loaded with Engineered Exosomes and Triple Anti-Tuberculosis Drugs with Potential for Treating Bone and Joint Tuberculosis. 2025;Volume 20:1285 doi: 10.2147/IJN.S480288 |
17 | Extracellular vesicles derived from host and gut microbiota as promising nanocarriers for targeted therapy in osteoporosis and osteoarthritis. 2023;13: doi: 10.3389/fphar.2022.1051134 |
18 | Bone-targeted engineered bacterial extracellular vesicles delivering miRNA to treat osteoporosis. 2023;267:111047 doi: 10.1016/j.compositesb.2023.111047 |
19 | Harnessing the therapeutic potential of bacterial extracellular vesicles via functional peptides. 2025; doi: 10.1002/INMD.20240125 |
20 | Rational Design of Multifunctional CuS Nanoparticle‐PEG Composite Soft Hydrogel‐Coated 3D Hard Polycaprolactone Scaffolds for Efficient Bone Regeneration. 2022;32: doi: 10.1002/adfm.202202470 |
21 | Extracellular Vesicles in Gut‐Bone Axis: Novel Insights and Therapeutic Opportunities for Osteoporosis. 2025;5: doi: 10.1002/smsc.202400474 |
22 | Lactobacillus rhamnosus-derived extracellular vesicles influence calcium deposition in a model of breast cancer intraductal calcium stress. 2025;28:112538 doi: 10.1016/j.isci.2025.112538 |
23 | Self-assembled co-delivery system of gold nanoparticles and paclitaxel based on in-situ dynamic covalent chemistry for synergistic chemo-photothermal therapy. 2025;44:417 doi: 10.1007/s12598-024-03047-3 |
24 | Bio-Inspired Nanocarriers Derived from Stem Cells and Their Extracellular Vesicles for Targeted Drug Delivery. 2023;15:2011 doi: 10.3390/pharmaceutics15072011 |
25 | Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease. 2022;13: doi: 10.3389/fphar.2022.909408 |
26 | Bacterial Extracellular Vesicles in Oncology: Molecular Mechanisms and Future Clinical Applications. 2025;17:1774 doi: 10.3390/cancers17111774 |
27 | Engineered bacterial extracellular vesicles for osteoporosis therapy. 2022;450:138309 doi: 10.1016/j.cej.2022.138309 |
28 | The siEGFR nanoplexes for the enhanced brain glioma treatment: Endoplasmic reticulum biomimetic strategy to induce homing effect and non-degradable intracellular transport. 2024;179:117413 doi: 10.1016/j.biopha.2024.117413 |
29 | Genetically Engineered Cellular Nanovesicles: Theories, Design and Perspective. 2024;34: doi: 10.1002/adfm.202407842 |
30 | Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases. 2022;8:e09575 doi: 10.1016/j.heliyon.2022.e09575 |
31 | Lipid Nanovesicles in Cancer Treatment: Improving Targeting and Stability of Antisense Oligonucleotides. 2025;Volume 19:1001 doi: 10.2147/DDDT.S507402 |
32 | Role of Legionella pneumophila outer membrane vesicles in host-pathogen interaction. 2023;14: doi: 10.3389/fmicb.2023.1270123 |
33 | New Insights into Pharmaceutical Nanocrystals for the Improved Topical
Delivery of Therapeutics in Various Skin Disorders. 2024;25:1182 doi: 10.2174/0113892010276223231027075527 |
34 | Revolutionizing cancer treatment via bioengineered extracellular vesicles: Exploring nanovesicles to fully synthetic solutions. 2024;40:102395 doi: 10.1016/j.apmt.2024.102395 |
35 | Bacterial extracellular vesicles in osteoarthritis: a new bridge of the gut-joint axis. 2025;17: doi: 10.1080/19490976.2025.2489069 |
36 | Bone-targeted biomaterials: Strategies and applications. 2022;446:137133 doi: 10.1016/j.cej.2022.137133 |
37 | Artificial pancreas with engineered β cell microspheres overexpressing PD-L1 and algae ameliorate type 1 diabetes. 2025;6:102549 doi: 10.1016/j.xcrp.2025.102549 |
38 | Selection and identification of a novel ssDNA aptamer targeting human skeletal muscle. 2023;20:166 doi: 10.1016/j.bioactmat.2022.05.016 |
39 | Current progression in application of extracellular vesicles in central nervous system diseases. 2024;29: doi: 10.1186/s40001-023-01606-5 |
40 | Genetically modified cell membrane proteins in tissue engineering and regenerative medicine. 2025;17:032004 doi: 10.1088/1758-5090/add625 |
41 | Characterization and assessment of lung and bone marrow derived endothelial cells and their bone regenerative potential. 2022;13: doi: 10.3389/fendo.2022.935391 |
42 | Engineered extracellular vesicles as intelligent nanosystems for next-generation nanomedicine. 2022;7:682 doi: 10.1039/D2NH00070A |
43 | Leveraging engineered yeast small extracellular vesicles serve as multifunctional platforms for effectively loading methyl salicylate through the “esterase-responsive active loading” strategy. 2025;210:114696 doi: 10.1016/j.ejpb.2025.114696 |
44 | Bacterial Extracellular Vesicles: Bridging Pathogen Biology and Therapeutic Innovation. 2025;200:1 doi: 10.1016/j.actbio.2025.05.028 |
45 | An interplay between non-coding RNAs and gut microbiota in human health. 2023;201:110739 doi: 10.1016/j.diabres.2023.110739 |
46 | Organoids and organoid extracellular vesicles-based disease treatment strategies. 2024;22: doi: 10.1186/s12951-024-02917-3 |
47 | Targeted microbubbles combined with low-power focused ultrasound promote the thrombolysis of acute deep vein thrombosis. 2023;11: doi: 10.3389/fbioe.2023.1163405 |
48 | Synthetic biology‐based bacterial extracellular vesicles displaying BMP‐2 and CXCR4 to ameliorate osteoporosis. 2024;13: doi: 10.1002/jev2.12429 |
49 | Microbiota and Extracellular Vesicles in Anti-PD-1/PD-L1 Therapy. 2022;14:5121 doi: 10.3390/cancers14205121 |
50 | Organoid‐tissue extracellular vesicles. 2025; doi: 10.1002/INMD.20250006 |
51 | Engineering Autologous Cell‐Derived Exosomes to Boost Melanoma‐Targeted Radio‐Immunotherapy by Cascade cGAS‐STING Pathway Activation. 2025;21: doi: 10.1002/smll.202408769 |
52 | Lactobacillus rhamnosus GG-derived extracellular vesicles promote wound healing via miR-21-5p-mediated re-epithelization and angiogenesis. 2024;22: doi: 10.1186/s12951-024-02893-8 |
53 | Bifidobacterium longum NSP001-derived extracellular vesicles ameliorate ulcerative colitis by modulating T cell responses in gut microbiota-(in)dependent manners. 2025;11: doi: 10.1038/s41522-025-00663-4 |
54 | Bacterial extracellular vesicles: biotechnological perspective for enhanced productivity. 2024;40: doi: 10.1007/s11274-024-03963-7 |
55 | Extracellular vesicles as carriers for protein and peptide therapeutics delivery: A review. 2025; doi: 10.1016/j.ipha.2025.05.001 |
56 | Human Breast Milk miRNAs: Their Diversity and Potential for Preventive Strategies in Nutritional Therapy. 2023;24:16106 doi: 10.3390/ijms242216106 |
57 | Extracellular vesicles of Lactiplantibacillus plantarum PCM 2675 and Lacticaseibacillus rhamnosus PCM 489: an introductory characteristic. 2024; doi: 10.20517/evcna.2024.49 |
58 | Engineered plant extracellular vesicles for autoimmune diseases therapy. 2024;17:2857 doi: 10.1007/s12274-023-6112-1 |
59 | Enhancing immunogenicity and release of in situ-generated tumor vesicles for autologous vaccines. 2025;381:113614 doi: 10.1016/j.jconrel.2025.113614 |
